Summary
This prediction ended on 19.02.19 with a price of €20.68. The BUY prediction by elbawind finished with a performance of 14.60%. elbawind has 50% into this predictionEvotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Evotec SE | 0.518% | 0.518% | -41.789% | -72.004% |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
Comments by elbawind for this prediction
In the thread Evotec AG diskutieren
Wo bleibt die Rally?
Das Jahr verlief bescheiden, wenn nicht beschi......Jetzt kann nur noch eine Rally . Ich setze weiter auf Evotec, denn die machten eine gute Entwicklung, wenn nicht die Unsicherheiten seit September eine Unterbrechung gebracht hätten. Seit Oktober zeigt die Aktie aber bereits Standvermögen: so rechne ich mit einer kurzfristigen Einstellung der Kurse vom Anfang September.